← Back to Search

Behavioral Intervention

Cognitive Remediation Therapy for Anorexia

N/A
Waitlist Available
Led By Catherine Alix Timko, PhD
Research Sponsored by Children's Hospital of Philadelphia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Currently meets Diagnostic and Statistical Manual-5 criteria for Anorexia Nervosa
Medically stable for outpatient treatment
Must not have
Pregnant adolescent
No more than four sessions of prior CRT in any format
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, during treatment, end of treatment
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if adding Cognitive Remediation Therapy (CRT) to Family Based Treatment (FBT) helps adolescents with Anorexia Nervosa (AN) by making their thinking more flexible. The goal is to see if this combined approach improves treatment outcomes. Cognitive Remediation Therapy (CRT) has been developed and tested for adolescents with anorexia nervosa to improve cognitive flexibility and holistic processing.

Who is the study for?
This trial is for adolescents aged 12-18 with Anorexia Nervosa who are stable enough for outpatient treatment and have no other major health issues. Parents or caregivers must be over 18, willing to participate, live with the adolescent, and provide medical clearance.
What is being tested?
The study tests if Cognitive Remediation Therapy (CRT) can improve 'set-shifting' (the ability to switch between tasks or thoughts) in teens with Anorexia Nervosa, potentially leading to better outcomes when combined with Family Based Treatment.
What are the potential side effects?
Since CRT involves psychological exercises rather than medication, typical side effects associated with drugs aren't expected. However, participants may experience stress or emotional discomfort during therapy sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Anorexia Nervosa.
Select...
I am stable enough to receive treatment without being hospitalized.
Select...
My child has been diagnosed with AN.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am a pregnant teenager.
Select...
I have had 4 or fewer sessions of chemotherapy or radiation therapy.
Select...
I am not within the specified age range for adolescents.
Select...
I have a brain condition or injury that might affect my treatment participation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, during treatment, end of treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, during treatment, end of treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in behavioral flexibility (amount consumed)
Change in behavioral flexibility (eating disorder behaviors)
Change in category switching flexibility
+9 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: FBT w/ Adolescent-focused Cognitive Remediation TherapyExperimental Treatment2 Interventions
Family Based Treatment with Adolescent-focused Cognitive Remediation Therapy (CRT): Families will receive 15 sessions of FBT over six months. The first 9 sessions of FBT will be preceded by adolescent-focused CRT.
Group II: Family Based Treatment (FBT)Active Control1 Intervention
Families will receive 15 sessions of FBT alone.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Remediation Therapy
2014
Completed Phase 4
~960
Family Based Treatment
2017
N/A
~380

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Cognitive Behavioral Therapy (CBT) is a common treatment for Anorexia Nervosa that focuses on changing maladaptive thought patterns and behaviors related to food, body image, and self-esteem. Enhancing set-shifting abilities, which refers to the cognitive flexibility to switch between tasks or thoughts, is particularly important in CBT for Anorexia Nervosa patients, as they often exhibit rigid thinking patterns. By improving set-shifting, CBT helps patients develop more adaptive coping strategies and reduces obsessive behaviors around food and body image. This matters for Anorexia Nervosa patients because it can lead to more sustainable recovery and improved quality of life. Other treatments, such as nutritional rehabilitation and family-based therapy, also play crucial roles by addressing the physical health and family dynamics that contribute to the disorder.

Find a Location

Who is running the clinical trial?

Children's Hospital of PhiladelphiaLead Sponsor
729 Previous Clinical Trials
8,469,989 Total Patients Enrolled
2 Trials studying Anorexia Nervosa
227 Patients Enrolled for Anorexia Nervosa
National Institute of Mental Health (NIMH)NIH
2,918 Previous Clinical Trials
2,739,682 Total Patients Enrolled
49 Trials studying Anorexia Nervosa
42,573 Patients Enrolled for Anorexia Nervosa
Catherine Alix Timko, PhDPrincipal InvestigatorChildren's Hospital of Philadelphia
1 Previous Clinical Trials
177 Total Patients Enrolled
1 Trials studying Anorexia Nervosa
177 Patients Enrolled for Anorexia Nervosa

Media Library

Cognitive Remediation Therapy (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05017831 — N/A
Anorexia Nervosa Research Study Groups: FBT w/ Adolescent-focused Cognitive Remediation Therapy, Family Based Treatment (FBT)
Anorexia Nervosa Clinical Trial 2023: Cognitive Remediation Therapy Highlights & Side Effects. Trial Name: NCT05017831 — N/A
Cognitive Remediation Therapy (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05017831 — N/A
~0 spots leftby Nov 2024